This inventor holds 10 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: Astellas Pharma Gmbh, Comentis, Inc., Kyoto University. Active years: 2011-2026.
Location History:
- Chuo-ku, JP (2011)
- Tokyo, JP (2013 - 2023)
Company Filing History:
8 out of 424 
2 out of 7 
1 out of 859 
Years Active: 2011-2026
Title: Hisao Hamaguchi: Pioneering Innovations in Tech
Introduction:
Hisao Hamaguchi, a visionary inventor based in Tokyo, JP, has made significant contributions to the global tech landscape with his relentless drive for innovation. With a total of 8 patents to his name, Hamaguchi is a respected figure in the field of technology and research.
Latest Patents:
Among his latest patents is a groundbreaking compound and method for producing regulatory T cells. This innovative approach involves utilizing CDK8 and/or CDK19 inhibitors to induce Foxp3 in T cells, ultimately leading to the production of Tregs. Additionally, his work on bicyclic nitrogen-containing aromatic heterocyclic amide compounds has shown promise in the treatment of breast cancer.
Career Highlights:
Hamaguchi's innovative spirit has led him to work with renowned companies such as Astellas Pharma GmbH and Comentis, Inc. Throughout his career, he has demonstrated a dedication to pushing the boundaries of what is possible in the realm of technology and healthcare.
Collaborations:
Collaborating with talented individuals is essential in the world of innovation. Hisao Hamaguchi has had the opportunity to work alongside industry experts such as Shigetoshi Kikuchi and Ryosuke Munakata, further amplifying the impact of his groundbreaking inventions.
Conclusion:
In conclusion, Hisao Hamaguchi's passion for innovation and his groundbreaking inventions have solidified his reputation as a visionary inventor in the global tech landscape. His relentless drive to push the boundaries of what is possible continues to inspire and pave the way for future breakthroughs in technology and healthcare.